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Knowledge, attitudes, and practices of
Florida physicians regarding dengue before
and after an educational intervention
Susanne Doblecki-Lewis1*, Aileen Chang2, Renee Jiddou-Yaldoo3, Kay M. Tomashek4, Danielle Stanek5,
Leena Anil6 and Paola Lichtenberger7
Abstract
Background: Failure to recognize and appropriately manage dengue early in the clinical course may result in late
initiation of supportive treatment for severe disease. In Florida, travel-related and autochthonous dengue occur and
are likely under-recognized. The objective of this study was to evaluate physician knowledge of dengue and its
management before and after an educational intervention in Florida.
Methods: From 2012–13 we conducted 14 grand-rounds style lectures on dengue clinical management attended
by 413 physicians, and analyzed data from the pre- and post-tests.
Results: Of those attending, 231 and 220 completed the pre-and post-tests, respectively. Overall, the mean pre-test
score for knowledge-based questions was 74.3 and average post-test score was 94.2 %, indicating a mean increase
of 19.9 % (P < 0.0001, 95 % CI 17.7–22.4). Reported confidence in dengue recognition and management also
increased. Non-US trained physicians and those who had treated more than ten dengue cases performed
significantly better in the pre-test. Post-test scores did not differ by subgroup.
Conclusions: The train-the-trainer approach with grand-rounds style presentations appear to be an effective
intervention to improve knowledge of dengue among physicians.
Keywords: Dengue, Clinical practice, Physician training, Evaluation, Survey
Background
Dengue is a mosquito-transmitted viral disease that is
endemic throughout the subtropics and tropics world-
wide. Clinical manifestations range from a mild acute
febrile illness to a severe life-threatening disease with a
plasma leakage syndrome resulting in hypovolemic
shock and hemorrhage [1]. Prior to 1940, dengue out-
breaks occurred regularly in Florida including approxi-
mately 15,000 cases from 1934–1935. Locally-acquired
dengue was not reported again in Florida until 2009–
2010 when 88 cases were detected in Monroe County,
Florida [2–4]. Since that time, a few sporadic locally-
acquired dengue cases have been reported from other
Florida counties including an outbreak in Martin County
in 2013 [5].
Florida is at risk for dengue outbreaks with locally
acquired dengue cases because of its largely non-
immune population, an abundance of the mosquito
vectors, Aedes aegypti and Aedes albopictus, and import-
ation of dengue virus via viremic tourists and residents
returning from neighboring dengue-endemic areas in-
cluding Mexico, Central and South American, and the
Caribbean. In fact, the majority of dengue cases reported
in Florida are travel-associated cases [3]. Florida is a
leading reporter of travel-associated dengue cases among
the U.S. states and in 2015, Florida was second only to
California [6]. Travel-associated cases may result in sub-
sequent autochthonous transmission [2, 5, 7].
While physicians in endemic areas are likely to con-
sider dengue in the differential diagnosis of a patient
presenting with an acute febrile illness [8], dengue may
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not be considered in non-endemic areas, leading to
under-diagnosis [9]. In the Key West 2009–2010 out-
break, initial cases were attributed by local physicians to
non-specific viral illness and the diagnosis of dengue
was not considered [4]. Similarly, in a 1999 dengue out-
break in Laredo, Texas, most patients identified as hav-
ing a recent dengue infection by serologic diagnostic
tests were initially given a clinical diagnosis of non-
specific viral syndrome and not dengue [9].
Early recognition of dengue cases and timely initiation
of appropriate supportive care is critical because it
has been shown to reduce medical complications and
mortality among patients with severe dengue [10–14].
As there is no licensed vaccine in the United States
to prevent dengue or antiviral medication to prevent
the development of severe disease manifestations,
educating clinicians on the recognition and clinical
management of dengue is an important public health
strategy [7]. Educating physicians regarding standard
clinical management protocols including how to iden-
tify e severe dengue have been demonstrated to re-
duce the case fatality rate associated with dengue
hemorrhagic syndrome [14].
Train-the-trainer interventions, in which a small group
of individuals receive in-depth training with the intent
to further disseminate information to a broader audi-
ence, have been used to train emergency room providers
in management of sickle cell disease, improve recogni-
tion and treatment of chronic fatigue syndrome, and
educate physicians in Puerto Rico in response to a den-
gue outbreak in 2010 [8, 15, 16]. These interventions
allow rapid scale-up of training initiatives and offer
promise for rapid dissemination of expert-level content
delivered in a local context by physicians within the
area.
In response to an increase in travel-associated dengue
cases and two outbreaks with several locally acquired
dengue cases, the Florida Department of Health (FDOH)
in collaboration with University of Miami and the
Centers for Disease Control and Prevention (CDC)
Dengue Branch developed a train-the-trainer initiative
to offer grand rounds-style presentations with con-
tinuing medical education (CME) credit for Florida
physicians with the goal of increasing early recogni-
tion and standardizing treatment of dengue cases.
This paper describes the initiative and results from
the pre- and post-training evaluation of attendees’ know-
ledge of dengue.
Methods
Study design
This study involved an evaluation of physician know-
ledge, attitudes, and practices regarding dengue before
and after the educational intervention.
Train-the-trainer symposium
CDC training materials that were used to train physician
master trainers in Puerto Rico in 2010 were adapted
[8, 17], and used to conduct a one-day, intensive
training symposium hosted at the University of Miami.
Symposium attendees included a select group of ten phy-
sicians from four counties in southern Florida who had
prior clinical experience and interest in dengue. The
symposium included presentations on the epidemiology,
clinical presentation, laboratory diagnosis, reporting re-
quirements, and clinical management of dengue.
Educational intervention
Following the symposium, a one-hour grand-rounds
style presentation was developed using the CDC training
materials. The presentation offered an overview of
dengue clinical characteristics, diagnosis, monitoring,
reporting, and treatment. The physicians attending the
training symposium delivered the presentations as part
of weekly grand rounds activities at venues within major
hospital networks and practices throughout Florida. Par-
ticipants in the grand rounds sessions were self-selected.
One CME credit was offered to attendees of the grand-
rounds presentations.
Evaluation of physician knowledge, attitudes,
and practices
To assess physician knowledge and attitudes and prac-
tices regarding dengue, a two page, 20-item question-
naire was administered before each presentation and
identical questions were repeated after the presentation.
The questionnaire assessed participant’s knowledge of
dengue virus and its transmission and the epidemiology,
diagnosis, reporting, and clinical management of dengue.
Questions regarding knowledge and practice were mul-
tiple choice questions. The instrument also asked partic-
ipants for their opinion on the relevance of dengue in
their medical practice and confidence in their ability to
diagnose and treat dengue patients. These were assessed
on a zero to ten scale with zero indicating “no confi-
dence or relevance at all” and ten “very confident/very
relevant.” Demographic information including age, years
in practice, medical specialty, and location of medical
school training was obtained in the pre-test. To preserve
confidentiality, pre- and post-tests were not linked. Only
those completing the pre-test were asked to complete
the post-test.
Ethics and informed consent
The study protocol was reviewed and approved by the
University of Miami Institutional Review Board (study
#20120015). A waiver of written informed consent was
granted by the Institutional Review Board. A verbal
consent script was presented at the beginning of the
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presentation and attendees were informed that comple-
tion of the survey was construed as consent to partici-
pate. All attendees were offered the option of not
participating.
Analysis
We conducted a descriptive analysis of participant
demographics characteristics, and compared pre- and
post-tests findings overall and by demographic groups.
The mean percentage of questions correctly answered in
the pre- and post-tests were compared using the un-
paired student’s t-test. For individual items of interest,
pre- and post-test responses were compared using the z-
test for comparison of proportion of respondents correctly
answering the question and the student’s t-test with Sat-
terthwaite method for unequal variances for continuous
scale responses. Statistical differences in baseline (pre-test)
scores were tested using analysis of variance and Tukey’s
post-hoc test. The relationship between continuous vari-
ables was calculated using Pearson correlation coefficient.
Paper questionnaires were completed in-person. Data ana-
lysis was conducted using SAS (v. 9.3; SAS Institute Inc.,
Cary, North Carolina) and graphs were produced in
Microsoft Excel (Microsoft Corp., Redmond, WA).
Results
A total of 413 physicians attended 14 dengue grand-
rounds presentations offered in Florida between January
2012 and October 2013. Of these, 231 (55.9 %) com-
pleted the pre-test and 220 (53.3 %) also completed the
post-test assessment. More than half of all pre-test re-
spondents were reportedly Internal Medicine physicians
(42.9 %) or Pediatricians (13.4 %) (Table 1). The majority
(68.4 %) of respondents were in practice for 0–5 years while
21.2 % were in practice for more than 10 years. Slightly
more than half (54.5 %) of respondents reportedly attended
medical school in the United States (U.S.) while 43 %
attended medical school in Central America, South Amer-
ica, or the Caribbean. Most (62.3 %) respondents indicated
they had never diagnosed a case of dengue; however,
nearly one-third of respondents had diagnosed at least
one dengue case. Non-U.S. educated physicians were
significantly more likely to report having diagnosed at
least one dengue case in their career (p < 0.0001).
Overall, the mean pre-test score for the knowledge-
based questions was 74.3 % and the average post-test
score was 94.2 %, indicating a mean increase of 19.9 %
(P < 0.0001, 95 % CI 17.7–22.4) (Table 2). The lowest
scoring questions in the pre-test involved identification
of clinically significant plasma leakage as the cardinal
feature distinguishing severe dengue from dengue
(27.3 % correct) and identification of the 1–2 day period
after defervescence as the critical phase for development
of severe manifestations (40.8 %). High scoring questions
included identification of mosquitoes as the vector
(98.7 %) and correct management of a patient with
warning signs for severe dengue during the critical phase
(91.5 %). Scores for all knowledge questions increased
from pre-test to post-test assessment.
Reported self-confidence in ability to recognize dengue
cases increased significantly from pre- to post-test as-
sessment from a mean of score of 4.1 to 7.0, respectively
(Table 2). Similarly, confidence in ability to treat dengue
cases increased from a mean of 3.9 in the pre-test to 7.2 in
the post-test. The assessment of the course relevance to
the respondent’s practice increased from 6.9 to 8.3 from
pre- to post-test. Greater confidence in recognition and
treatment of dengue prior to the presentation were signifi-
cantly associated with better performance on the pre-test
(r = 0.34, p < 0.001 for recognition; r = 0.35, p < 0.001 for
treatment). Perceived relevance to their own medical prac-
tice also demonstrated a weak but significant correlation
with pre-test scores (r = 0.18, p < 0.007).
Table 1 Demographic characteristics of physicians completing
pre-test dengue surveys (n = 231)
Medical specialty N (%)
Internal Medicine 99 42.9
Pediatrics 31 13.4
Dermatology 21 9.1
Infectious Diseases 13 5.6
Emergency Medicine 8 3.5
Internal Medicine/Pediatrics 6 2.6
Family Practice 3 1.3
Other/No Answer 50 21.6
Years in Practice N (%)
0–5 158 68.4
6–10 16 6.9
> 10 49 21.2
No Answer 8 3.5
Dengue Cases Treated N (%)
0 144 62.3
1–5 46 19.9
6–10 5 2.2
> 10 18 7.8
No Answer 18 7.8
Medical School N (%)
In United States 126 54.5
Oustide U.S. 99 42.9
Other/No Answer 6 2.6
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Average test scores varied by respondent demographic
characteristics. Respondents trained at a non-U.S. med-
ical school had higher pre-test scores compared with
those educated in the U.S. (76.7 % vs. 72.7 %; p = 0.036).
Similarly, those who reported diagnosing more than 10
cases of dengue had higher pre-test scores than those
who reported having never diagnosed a dengue case
(83.8 % vs. 72.0 %; p = 0.0003). Respondents who report-
edly had never diagnosed a patient with dengue had a
significantly greater increase in test score from pre-to
post-test compared with those who had diagnosed the
most cases (+23.0 % vs. +6.8 %; p < 0.0001); post-test
scores were not significantly different by number of den-
gue cases diagnosed. Pre-test and post-test scores did
not significantly differ by years in practice.
Discussion
In our assessment of Florida physicians attending a
grand-rounds style presentation on dengue, we found
wide variability in baseline knowledge and confidence
regarding dengue diagnosis and management. For ex-
ample, physicians trained at non-U.S. medical schools, in
areas where dengue is endemic, reportedly had more
experience diagnosing dengue and scored significantly
higher on the pre-test than U.S. medical school gradu-
ates and those who had never diagnosed a case of
dengue. Physician pre-test confidence regarding dengue
diagnosis and treatment was also low at baseline, how-
ever those with higher pre- test scores tended to report
higher levels of confidence.
Knowledge presented in this format appeared to be
at a level accessible to practicing physicians with or
without prior experience with the disease, and was
successful in increasing knowledge and confidence re-
garding the essential features of diagnosis and treat-
ment of dengue. For example, despite lower baseline
knowledge, physicians with no clinical experience with
dengue patients and those educated in U.S. medical
schools made significantly greater gains from pre-test
to post-test than more experienced physicians trained
in non U.S. medical schools. In fact, post-test scores
did not differ by demographic characteristics and
overall test scores were high. In addition, perceived
relevance to practice and confidence regarding dengue
diagnosis and treatment demonstrated significant
gains following the presentation indicating an improved
Table 2 Physician survey test results before and after attending training
Test responses mean (SD) Pre-test Post-test p-valuea
n = 231 n = 220
Overall mean number of questions correct 74.3 (14.1) 94.2 (8.7) <0.001
Knowledge Responses (% who correctly identified)
Background
Type of organism that causes dengue is a virus 192/230 (83.5 %) 219/221 (99.1 %) <0.001
Vector of the disease is a mosquito 227/229 (99.1 %) 221/221 (100 %) 0.16
Infection with one serotype gives lifelong immunity to that serotype 197/224 (83.2 %) 201/215 (93.5 %) 0.05
Intrinsic incubation period within the human 188/226 (83.2 %) 201/218 (92.2 %) <0.001
Diagnosis
Cardinal feature distinguishing severe dengue from non-severe cases 60/220 (27.3 %) 198/218 (90.8 %) <0.001
Timing of the critical phase in dengue 89/218 (40.8 %) 197/215 (91.6 %) <0.001
Optimal timing to send sample for PCR laboratory diagnosis 132/213 (62.0 %) 178/209 (85.2 %) <0.001
Management
Medication used for fever control in a suspected dengue patient 150/223 (67.3 %) 200/215 (93.0 %) <0.001
Most appropriate treatment for a dengue patient 203/224 (90.6 %) 221/221 (100 %) <0.001
Management of a suspected dengue patient with warning signs 205/224 (91.5 %) 210/219 (95.9 %) 0.06
Fatality rate with proper recognition and early treatment 133/222 (59.9 %) 194/215 (90.2 %) <0.001
Timing requirements for reporting to local health department 24/222 (10.8 %) 60/215 (27.9 %) <0.001
Attitudinal Responses (scale 0–10) Mean (SD)
Level of confidence recognizing dengue cases (n = 216) 4.1 (2.9) 7.0 (2.1) <0.001
Level of confidence treating dengue cases (n = 215) 3.9 (3.2) 7.2 (2.2) <0.001
Relevance of dengue in their clinical practice (n = 215) 6.9 (2.8) 8.3 (1.9) <0.001
aComparison using paired, Students t-test with an alpha set to 0.05
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recognition of the importance of dengue among Florida
physician attendees.
The finding of differences in dengue knowledge by lo-
cation of medical school is not unexpected given the
small number of dengue cases likely to be encountered
by a U.S. medical student during their clinical rotations
and the lack of consistent inclusion of tropical medicine
education in U.S. medical school curricula [18]. How-
ever, physician surveys in areas where dengue is endemic
and commonly diagnosed have also demonstrated lack
of concordance of practice with available guidelines, lack
of recognition of the critical phase of illness, and sub-
optimal compliance with Department of Health case
reporting requirements [8, 19, 20]. Of concern, the rec-
ognition of the critical phase of infection in which symp-
toms may dramatically worsen and correct identification
of warning signs were content areas frequently missed in
our baseline survey as well as in a recent physician sur-
vey conducted in Puerto Rico [8]. Early identification of
the warning signs for development of severe dengue can
result in more appropriate monitoring and intensive
supportive care for more severe symptoms, interventions
that have been demonstrated to decrease morbidity and
mortality [10–14].
Limitations of this study include non-completion of
surveys from some attendees and lack of long-term
follow-up to determine retention of knowledge gained.
Additionally, while only those participating in the pre-
intervention survey were asked to complete the post-
intervention survey, the pre- and post-intervention
surveys were not individually linked and demographic
information was collected only in the pre-intervention
survey. Thus, there is the possibility that the individuals
completing the post-intervention survey may have dif-
fered from those completing the pre-intervention survey.
In addition, our study did not investigate if the increase
in knowledge and change in attitude demonstrated by
respondents led to a change in clinical practice, improved
case recognition, or increased testing of suspected cases
among attendees. Nevertheless, this assessment and edu-
cational program was successful in assessing baseline
knowledge of Florida physicians and in disseminating in-
formation regarding a locally important disease to many
physicians over a short period of time.
Conclusions
Within the continental United States, Florida is one of
the states with both a significant number of imported
cases of dengue as well as autochthonous transmission
[2]. Early recognition and timely, appropriate treatment
of dengue is the cornerstone of public health efforts to
mitigate local transmission and optimize patients’ clinical
outcomes [7]. Ensuring that Florida physicians know how
to recognize potential dengue cases, order appropriate
diagnostic tests, and notify public health officials is there-
fore a priority for any dengue response plan. Further, clin-
ician awareness of the clinical course of dengue including
the timing of the critical phase is necessary to offer correct
anticipatory guidance for dengue patients and make timely
referrals for patients demonstrating warning signs of
severe dengue. With increasing international travel and
resultant globalization of communicable diseases, there is
a need for expanded training for U.S. physicians in the
management of tropical diseases [21]. Expanding the
traditional medical school curricula to address common
emerging tropical diseases affecting travelers and new im-
migrants may be warranted [22–24]. The train-the-trainer
approach and grand-rounds style presentations appear to
be an effective intervention to improve knowledge, confi-
dence, and awareness of the importance of tropical dis-
eases that affect Floridians.
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